Apellis Pharmaceuticals, Inc

(NASDAQ:APLS)

Latest On Apellis Pharmaceuticals, Inc (APLS):

Date/Time Type Description Signal Details
2023-05-25 17:48 ESTNewsApellis and Sobi to drop ALS candidate on Phase 2 setbackN/A
2023-05-18 17:01 ESTNewsApellis Pharmaceuticals: Biotech's Rising Star In C3 Inhibition SpaceN/A
2023-05-06 12:27 ESTNewsApellis Pharmaceuticals, Inc. 2023 Q1 - Results - Earnings Call PresentationN/A
2023-05-06 12:27 ESTNewsApellis Pharmaceuticals, Inc. (APLS) Q1 2023 Earnings Call TranscriptN/A
2023-05-04 22:14 ESTNewsApellis Pharmaceuticals: Maintain 'Buy' Following Astellas' $5.9 Billion Acquisition Of Iveric BioN/A
2023-05-04 22:14 ESTNewsApellis Pharmaceuticals GAAP EPS of -$1.56 misses by $0.10, revenue of $44.84M beats by $18.74MN/A
2023-05-03 20:58 ESTNewsApellis Pharmaceuticals Q1 2023 Earnings PreviewN/A
2023-05-01 19:14 ESTNewsApellis weakness on Iveric Bio takeout is buying opportunity - analystN/A
2023-05-01 06:55 ESTNewsApellis Pharmaceuticals (APLS) Presents at the Association for Research in Vision and Ophthalmology Annual Meeting - SlideshowN/A
2023-04-03 17:26 ESTNewsApellis Pharmaceuticals may be worth $90-$100 a share in sale - analystN/A
2023-04-02 23:22 ESTNewsApellis Pharmaceuticals sees takeover interest from large pharma - BloombergN/A
2023-03-24 22:48 ESTNewsApellis Pharmaceuticals Is Poised For Dominance In Geographic Atrophy MarketN/A
2023-03-16 14:19 ESTNewsApellis Pharmaceuticals' Empaveli sNDA action date extended by FDAN/A
2023-02-23 11:44 ESTNewsApellis Pharmaceuticals prices $350M in stock offeringN/A
2023-02-22 09:58 ESTNewsApellis Pharmaceuticals to raise $300M in stock and warrants offeringN/A
2023-02-21 21:29 ESTNewsApellis Pharmaceuticals GAAP EPS of -$1.50 beats by $0.06, revenue of $22.66M misses by $1.86MN/A
2023-02-18 02:43 ESTNewsApellis wins FDA nod for eye disorder therapyN/A
2023-01-27 18:43 ESTNewsApellis: Empaveli Ought To Win Approval For Eye Disease In February - The Future Looks BrightN/A
2023-01-21 14:26 ESTNewsStocks To Watch: Earnings Heat Up, Healthcare Catalysts And M&A WildcardsN/A
2023-01-05 20:02 ESTNewsApellis appoints Baumal as Chief Medical OfficerN/A
2023-01-04 02:30 ESTNewsApellis, Arvinas lower as Wells Fargo downgrades in 2023 biotech previewN/A
2022-12-15 23:44 ESTNewsApellis Pharmaceuticals: Approval Is Baked Into ValuationN/A
2022-11-18 10:24 ESTNewsApellis surges 17% as FDA accepts to review new data in filing for eye disorder drugN/A
2022-11-11 06:07 ESTNewsApellis, IVERIC bio cut to Hold at Jefferies; says Street overestimates GA marketN/A
2022-11-08 08:01 ESTNewsApellis Pharmaceuticals GAAP EPS of -$1.75 misses by $0.29, revenue of $22.05M beats by $0.46MN/A
2022-11-08 08:00 ESTNewsApellis Pharmaceuticals, Inc. (APLS) Q3 2022 Earnings Call TranscriptN/A
2022-11-05 08:22 ESTNewsApellis Pharmaceuticals Q3 2022 Earnings PreviewN/A
2022-11-03 23:08 ESTNewsApellis sinks 20% as FDA review period for eye disease drug extendsN/A
2022-10-16 23:00 ESTNewsCiti lists four more value-creating events in biotech for this yearN/A
2022-09-29 06:33 ESTNewsApellis Pharmaceuticals: Trying To Develop A Blockbuster FranchiseN/A
2022-09-08 07:22 ESTNewsApellis gains as FDA says AdCom unnecessary for eye disease candidateN/A
2022-08-24 16:51 ESTNewsApellis stock dips amid 2-year data of pegcetacoplan for eye disorderN/A
2022-08-09 18:37 ESTNewsApellis Pharmaceuticals, Inc. 2022 Q2 - Results - Earnings Call PresentationN/A
2022-08-09 18:37 ESTNewsApellis Pharmaceuticals, Inc. (APLS) CEO Cedric Francois on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-08 18:56 ESTNewsApellis Pharmaceuticals GAAP EPS of -$1.46 misses by $0.09, revenue of $16.32M misses by $0.63MN/A
2022-08-06 06:05 ESTNewsApellis Pharmaceuticals Q2 2022 Earnings PreviewN/A
2022-07-27 15:50 ESTNewsApellis to exchange $75.6M in convertible senior notes for common stockN/A
2022-07-20 18:36 ESTNewsApellis Pharmaceuticals: The Meaning Of Priority Review For Pegcetacoplan For Geographic AtrophyN/A
2022-07-20 03:57 ESTNewsWainwright sees blockbuster potential for Apellis eye degeneration therapy; shares up 22%N/A
2022-07-19 13:21 ESTNewsApellis stock soars 24% as FDA grants priority review to pegcetacoplan for eye disorderN/A
2022-07-19 13:19 ESTNewsH.C. Wainwright sees blockbuster potential for Apellis' treatment in eye degenerationN/A
2022-06-25 15:25 ESTNewsApellis: Mixed Data, But Definitely Approvable In GAN/A
2022-06-13 19:55 ESTNewsHot Stocks: APLS & SKIL both gain, TSLA declined despite upgrade, and VLTA plungedN/A
2022-06-10 11:34 ESTNewsApellis/Sobi Empaveli shows benefit in rare blood disorder patients in new analysesN/A
2022-06-01 11:05 ESTNewsApellis files for FDA approval of pegcetacoplan to treat eye disorderN/A
2022-05-06 19:17 ESTNewsApellis Pharmaceuticals, Inc. 2022 Q1 - Results - Earnings Call PresentationN/A
2022-05-06 19:15 ESTNewsApellis Pharmaceuticals (APLS) Investor Presentation - SlideshowN/A
2022-05-04 22:43 ESTNewsApellis Pharmaceuticals GAAP EPS of -$1.42 misses by $0.12, revenue of $12.1M misses by $0.52MN/A
2022-05-04 22:42 ESTNewsApellis Pharmaceuticals, Inc. (APLS) CEO Cedric Francois on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-04 03:15 ESTNewsApellis Pharmaceuticals Q1 2022 Earnings PreviewN/A

About Apellis Pharmaceuticals, Inc (APLS):

Apellis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. Its lead product candidate is pegcetacoplan that is in Phase III clinical trials for the treatment of geographic atrophy in age-related macular degeneration and paroxysmal nocturnal hemoglobinuria (PNH) diseases; cold agglutinin disease; C3 glomerulopathy; and other glomerular diseases, such as IgA nephropathy, primary membranous nephropathy, and lupus nephritis. The company also develops APL-9, which is in single ascending dose Phase I randomized, double-blind, and placebo-controlled clinical trials for the prevention of immune system activation coincident with adeno-associated virus for intravenous administration, as well as is in Phase I/II clinical trial for acute respiratory distress syndrome. It has a collaboration and license agreement with Swedish Orphan Biovitrum AB (publ) to co-develop pegcetacoplan. The company was incorporated in 2009 and is based in Waltham, Massachusetts.

See Advanced Chart

General

  • Name Apellis Pharmaceuticals, Inc
  • Symbol APLS
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 374
  • Fiscal Year EndDecember
  • IPO Date2017-11-09
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.apellis.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 13.99
  • Price/Book (Most Recent Quarter) 18.33
  • Enterprise Value Revenue 12.97
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$6.46
  • Next Year EPS Estimate -$5.31
  • Next Quarter EPS Estimate -$1.60
  • Profit Margin -138%
  • Operating Margin -85%
  • Return on Assets -20%
  • Return on Equity -289%
  • Revenue 250.65 million
  • Earnings Per Share -$3.32
  • Revenue Per Share $3.34
  • Gross Profit -74325000
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 3.54 billion
  • Analyst Target Price $64.14
  • Book Value Per Share $2.69
View More

Share Statistics

  • Shares Outstanding 80.38 million
  • Shares Float 59.7 million
  • % Held by Insiders 2117%
  • % Held by Institutions 82.85%
  • Shares Short 8.11 million
  • Shares Short Prior Month 7.75 million
  • Short Ratio 13.44
  • Short % of Float 15%
  • Short % of Shares Outstanding 10%
View More

Technicals

  • Beta 1.52
  • 52 Week High $58.47
  • 52 Week Low $21.84
  • 50 Day Moving Average 46.47
  • 200 Day Moving Average 42.62
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Apellis Pharmaceuticals, Inc (APLS) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Apellis Pharmaceuticals, Inc (APLS) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-25$N/A$0.93-$0.45304.58%
2020-09-302020-11-02$646000-$1.79-$1.58-13.31%
2020-06-302020-07-30$N/A-$1.57-$1.34-17.56%
2020-03-312020-04-29$N/A-$2.29-$1.39-64.72%
2019-12-312020-02-27$N/A-$1.77-$1.14-55%
2019-09-302019-11-05$N/A-$1.10-$1.03-6.44%
2019-06-302019-07-31$N/A-$1.12-$0.78-44.39%
2019-03-312019-05-07$N/A-$0.87-$0.68-27.49%
2018-12-312019-02-26$N/A-$0.65-$0.707.58%
2018-09-302018-11-13$N/A-$0.64-$0.697.02%
2018-06-302018-07-31$N/A-$0.61-$0.42-45.86%
2018-03-312018-04-30$N/A-$0.43-$0.27-57.28%
2017-12-312018-03-19$N/A-$0.61-$0.27-129.32%
2017-09-302017-12-20$N/A-$0.23-$0.242.75%

Apellis Pharmaceuticals, Inc (APLS) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Apellis Pharmaceuticals, Inc (APLS) Chart:

Apellis Pharmaceuticals, Inc (APLS) News:

Below you will find a list of latest news for Apellis Pharmaceuticals, Inc (APLS) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Apellis Pharmaceuticals, Inc (APLS) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2024-05-17250CALL0 0138.56TRUE00
2024-05-173022.2CALL0 2102.38TRUE00
2024-05-17350CALL0 098.6TRUE00
2024-05-174016.94CALL0 179.74TRUE00
2024-05-17455.3CALL0 25081.73TRUE00
2024-05-17504CALL114 168281.08FALSE0.80.25
2024-05-17551.98CALL25 22677.26FALSE0.280.16
2024-05-17601.08CALL155 29481.2FALSE0.230.27
2024-05-17650.55CALL18 96482.99FALSE00
2024-05-17700.5CALL2 1596.67FALSE0.50
2024-05-17750.15CALL0 5989.61FALSE00
2024-05-17800CALL0 00FALSE00
2024-05-17850.55CALL0 60FALSE00
2024-05-17900.51CALL0 30FALSE00
2024-05-17250PUT0 00FALSE00
2024-05-17300PUT0 00FALSE00
2024-05-17350PUT0 00FALSE00
2024-05-17400.75PUT350 13188.35FALSE0.750
2024-05-17452.3PUT0 343378.46FALSE00
2024-05-17504.06PUT4 27383.94TRUE4.060
2024-05-17559.07PUT0 1678.43TRUE00
2024-05-176012.87PUT0 684.08TRUE00
2024-05-17650PUT0 091.74TRUE00
2024-05-17700PUT0 0108.8TRUE00
2024-05-17750PUT0 0114.89TRUE00
2024-05-17800PUT0 0119.53TRUE00
2024-05-17850PUT0 0134.45TRUE00
2024-05-17900PUT0 0145.42TRUE00
2024-06-21100CALL0 0358.1TRUE00
2024-06-2112.50CALL0 0214.5TRUE00
2024-06-211533.04CALL0 0169.14TRUE00
2024-06-2117.512.6CALL0 1122.31TRUE00
2024-06-212050.1CALL0 3102.63TRUE00
2024-06-2122.523.9CALL0 0104.06TRUE00
2024-06-212539.2CALL0 763.2TRUE00
2024-06-213026CALL0 60583.48TRUE00
2024-06-213513.2CALL0 12472.38TRUE00
2024-06-21409.4CALL0 19963.47TRUE00
2024-06-21456.7CALL0 3966.62TRUE00
2024-06-21504.13CALL0 18866.74FALSE00
2024-06-21553.15CALL13 66062.44FALSE3.150
2024-06-21602CALL238 28064.22FALSE0.230.13
2024-06-21651CALL0 192265.04FALSE00
2024-06-21700.55CALL0 117066.55FALSE00
2024-06-21750.52CALL2 9068.73FALSE0.520
2024-06-21801.25CALL0 440FALSE00
2024-06-21850.35CALL0 1190FALSE00
2024-06-21900.65CALL0 690FALSE00
2024-06-21950.45CALL0 510FALSE00
2024-06-211002CALL0 790FALSE00
2024-06-211052.65CALL0 310FALSE00
2024-06-211100.1CALL0 1040FALSE00
2024-06-211150.9CALL0 130FALSE00
2024-06-211201.5CALL0 60FALSE00
2024-06-211250.83CALL0 40FALSE00
2024-06-211300.7CALL0 610FALSE00
2024-06-211350.19CALL0 2850FALSE00
2024-06-21100PUT0 00FALSE00
2024-06-2112.50.1PUT0 50FALSE00
2024-06-21152.5PUT0 00FALSE00
2024-06-2117.50.5PUT0 120FALSE00
2024-06-21200.37PUT0 160FALSE00
2024-06-2122.50.9PUT0 00FALSE00
2024-06-21250.3PUT0 5480FALSE00
2024-06-21300.5PUT0 230FALSE00
2024-06-21350.4PUT1 18072.41FALSE0.40
2024-06-21401.35PUT0 10767.51FALSE00
2024-06-21452.85PUT0 20165.84FALSE00
2024-06-21504.9PUT29 95764.47TRUE-0.8-0.14
2024-06-215510.1PUT0 53064.89TRUE00
2024-06-216013.23PUT0 105166.31TRUE00
2024-06-216514.23PUT0 38866.03TRUE00
2024-06-217014.8PUT0 6664.4TRUE00
2024-06-217515.3PUT0 4760.36TRUE00
2024-06-218024.31PUT0 7874.55TRUE00
2024-06-218520.2PUT0 088.6TRUE00
2024-06-219033PUT0 107981.87TRUE00
2024-06-219535.8PUT0 095.6TRUE00
2024-06-2110038.5PUT0 094.01TRUE00
2024-06-211050PUT0 0138TRUE00
2024-06-211100PUT0 0104.88TRUE00
2024-06-211150PUT0 0121.28TRUE00
2024-06-211200PUT0 0157.91TRUE00
2024-06-211250PUT0 0163.16TRUE00
2024-06-211300PUT0 0160.11TRUE00
2024-06-2113586.3PUT0 0167.66TRUE00
2024-07-19250CALL0 0107.01TRUE00
2024-07-19300CALL0 091.99TRUE00
2024-07-19350CALL0 061.32TRUE00
2024-07-194012.19CALL1 163.91TRUE12.190
2024-07-19457.2CALL0 2262.25TRUE00
2024-07-19506CALL5 1259.98FALSE60
2024-07-19554.6CALL0 3959.35FALSE00
2024-07-19602.75CALL31 13160.77FALSE2.750
2024-07-19651.78CALL1 10260.57FALSE0.310.21
2024-07-19700.95CALL0 2459.44FALSE00
2024-07-19750.7CALL2 207260.04FALSE0.70
2024-07-19800.8CALL0 961.12FALSE00
2024-07-19852.65CALL0 461.17FALSE00
2024-07-19904.5CALL0 600FALSE00
2024-07-19951.65CALL0 6790FALSE00
2024-07-191000.4CALL0 4000FALSE00
2024-07-191050.44CALL0 310FALSE00
2024-07-19250PUT0 00FALSE00
2024-07-19302.33PUT0 10FALSE00
2024-07-19352.32PUT0 467.54FALSE00
2024-07-19401.15PUT0 1663.66FALSE00
2024-07-19454.3PUT0 6262.83FALSE00
2024-07-19505.7PUT4 5862.23TRUE5.70
2024-07-195510.27PUT0 208260.26TRUE00
2024-07-196010.7PUT0 12360.12TRUE00
2024-07-196518.7PUT0 9662.01TRUE00
2024-07-197013.5PUT0 262.48TRUE00
2024-07-197521PUT0 668.01TRUE00
2024-07-198018.8PUT0 677.7TRUE00
2024-07-198530.67PUT0 090.66TRUE00
2024-07-19900PUT0 071.43TRUE00
2024-07-19950PUT0 098.44TRUE00
2024-07-191000PUT0 099.37TRUE00
2024-07-191050PUT0 097.04TRUE00
2024-10-18250CALL0 053.16TRUE00
2024-10-183021.42CALL0 457.95TRUE00
2024-10-18350CALL0 064.12TRUE00
2024-10-18400CALL0 061.48TRUE00
2024-10-18450CALL0 065.37TRUE00
2024-10-185010.2CALL0 658.41FALSE00
2024-10-18555.25CALL0 1157.58FALSE00
2024-10-18603.3CALL0 106158.51FALSE00
2024-10-18653.5CALL1 155.33FALSE3.50
2024-10-18702.84CALL1 6957.3FALSE2.840
2024-10-18752.75CALL0 1357.1FALSE00
2024-10-18803.52CALL0 257.09FALSE00
2024-10-18852.7CALL0 157.03FALSE00
2024-10-18900CALL0 058.11FALSE00
2024-10-18950CALL0 055.52FALSE00
2024-10-181000CALL0 059.35FALSE00
2024-10-181051.25CALL0 157.36FALSE00
2024-10-18250PUT0 00FALSE00
2024-10-18300.8PUT0 368.04FALSE00
2024-10-18351.63PUT0 262.62FALSE00
2024-10-18402.45PUT0 1461.17FALSE00
2024-10-18455.1PUT0 3660.12FALSE00
2024-10-18508.45PUT0 6359.5TRUE00
2024-10-185512.2PUT0 557.99TRUE00
2024-10-186010.3PUT0 658.5TRUE00
2024-10-186513.2PUT0 2163TRUE00
2024-10-18700PUT0 056.88TRUE00
2024-10-18750PUT0 056.77TRUE00
2024-10-18800PUT0 059.48TRUE00
2024-10-18850PUT0 060.12TRUE00
2024-10-18900PUT0 060.61TRUE00
2024-10-18950PUT0 068.33TRUE00
2024-10-181000PUT0 080.1TRUE00
2024-10-181050PUT0 079.4TRUE00
2024-12-201053.2CALL0 1113.51TRUE00
2024-12-2012.551.1CALL0 195.79TRUE00
2024-12-20150CALL0 090.45TRUE00
2024-12-2017.514.67CALL0 386.61TRUE00
2024-12-202045CALL0 877.31TRUE00
2024-12-2022.538.3CALL0 373.31TRUE00
2024-12-202531CALL0 6657.53TRUE00
2024-12-203027.9CALL0 761.4TRUE00
2024-12-203516.19CALL0 2861.8TRUE00
2024-12-204017CALL0 860.56TRUE00
2024-12-204519.5CALL0 1860.3TRUE00
2024-12-205020.7CALL0 1659.21FALSE00
2024-12-20556.8CALL0 2457.97FALSE00
2024-12-20607.45CALL0 110557.72FALSE00
2024-12-20656.05CALL0 46957.49FALSE00
2024-12-20703CALL0 130055.22FALSE00
2024-12-20754CALL0 11457.19FALSE00
2024-12-20802CALL0 172956.59FALSE00
2024-12-20854.5CALL0 79956.48FALSE00
2024-12-20903.5CALL0 24256.79FALSE00
2024-12-20951.6CALL0 20455.95FALSE00
2024-12-201004.4CALL0 356.61FALSE00
2024-12-201054CALL0 2455.57FALSE00
2024-12-201101.55CALL0 156.1FALSE00
2024-12-201151.2CALL0 156.14FALSE00
2024-12-201200CALL0 055.58FALSE00
2024-12-201250CALL0 00FALSE00
2024-12-201301.66CALL0 130FALSE00
2024-12-201350.64CALL0 390FALSE00
2024-12-20100.3PUT0 10FALSE00
2024-12-2012.51PUT0 10FALSE00
2024-12-20153.5PUT0 30FALSE00
2024-12-2017.52.07PUT0 50FALSE00
2024-12-20200.4PUT0 420FALSE00
2024-12-2022.51.22PUT0 360FALSE00
2024-12-20251.63PUT0 1966.99FALSE00
2024-12-20301.5PUT0 5965.08FALSE00
2024-12-20351.45PUT0 7962.62FALSE00
2024-12-20403.5PUT0 8261.37FALSE00
2024-12-20454.44PUT0 5360.13FALSE00
2024-12-20507.8PUT0 53859.77TRUE00
2024-12-20556PUT0 14558.44TRUE00
2024-12-206010.4PUT0 11958.28TRUE00
2024-12-206513.4PUT0 16455.98TRUE00
2024-12-20700PUT0 057.14TRUE00
2024-12-207516PUT0 1157.47TRUE00
2024-12-20800PUT0 056.47TRUE00
2024-12-208528.9PUT0 254.56TRUE00
2024-12-209054.2PUT0 2057.22TRUE00
2024-12-209562.6PUT0 665.82TRUE00
2024-12-201000PUT0 068.95TRUE00
2024-12-2010545.62PUT0 071.02TRUE00
2024-12-201100PUT0 075.19TRUE00
2024-12-201150PUT0 077.64TRUE00
2024-12-201200PUT0 079.03TRUE00
2024-12-201250PUT0 082.83TRUE00
2024-12-201300PUT0 086.49TRUE00
2024-12-201350PUT0 088.36TRUE00
2025-01-171052.45CALL0 0108.4TRUE00
2025-01-1712.531.5CALL0 2104.8TRUE00
2025-01-17150CALL0 089.98TRUE00
2025-01-1717.531.1CALL0 284.99TRUE00
2025-01-172046.11CALL0 18469.05TRUE00
2025-01-1722.548CALL0 14671.14TRUE00
2025-01-172539.5CALL0 8261.2TRUE00
2025-01-173029.8CALL0 15661TRUE00
2025-01-173519CALL0 7060.98TRUE00
2025-01-174021CALL0 8060.09TRUE00
2025-01-174516.97CALL0 1559.14TRUE00
2025-01-17509.6CALL0 58657.96FALSE00
2025-01-17559.67CALL0 12657.63FALSE00
2025-01-17605.5CALL0 117357.14FALSE00
2025-01-17655.3CALL0 40356.73FALSE00
2025-01-17705CALL0 19256.07FALSE00
2025-01-17753.2CALL0 45353.62FALSE00
2025-01-17802.78CALL1 13354.98FALSE2.780
2025-01-17854.7CALL0 13755.84FALSE00
2025-01-17902.25CALL0 13154.86FALSE00
2025-01-17953.8CALL0 33456.06FALSE00
2025-01-171001.05CALL0 5055.38FALSE00
2025-01-171055.1CALL0 1856.97FALSE00
2025-01-171102.7CALL0 254.81FALSE00
2025-01-171150.8CALL0 2655.95FALSE00
2025-01-171200CALL0 055.48FALSE00
2025-01-171251CALL0 19256.49FALSE00
2025-01-171300.75CALL0 1210FALSE00
2025-01-171350.6CALL0 3960FALSE00
2025-01-17100.3PUT0 90FALSE00
2025-01-1712.50.1PUT0 1090FALSE00
2025-01-17150PUT0 00FALSE00
2025-01-1717.52PUT0 150FALSE00
2025-01-17201PUT0 70FALSE00
2025-01-1722.51.23PUT0 80FALSE00
2025-01-17250.9PUT0 15766.25FALSE00
2025-01-17301.4PUT0 10363.24FALSE00
2025-01-17353PUT60 54063.25FALSE30
2025-01-17405.3PUT0 71560.43FALSE00
2025-01-17456.22PUT20 4657.5FALSE6.220
2025-01-175010.32PUT0 16458.02TRUE00
2025-01-17559.5PUT0 9857.39TRUE00
2025-01-176012.3PUT0 16157.03TRUE00
2025-01-176515.5PUT0 18457.24TRUE00
2025-01-177018.76PUT0 29160.31TRUE00
2025-01-177521.4PUT0 2556.5TRUE00
2025-01-178024.8PUT0 555.91TRUE00
2025-01-178528.78PUT0 756.02TRUE00
2025-01-179040.16PUT0 81356.94TRUE00
2025-01-179531.5PUT0 5055.95TRUE00
2025-01-1710041.97PUT0 063.7TRUE00
2025-01-1710555.9PUT0 070.06TRUE00
2025-01-1711054.9PUT0 070.4TRUE00
2025-01-171150PUT0 070.33TRUE00
2025-01-1712064PUT0 074.41TRUE00
2025-01-1712576.28PUT0 078.33TRUE00
2025-01-171300PUT0 080.99TRUE00
2025-01-1713587.75PUT0 084.66TRUE00
2026-01-162030CALL0 153.7TRUE00
2026-01-1622.537.3CALL0 159.71TRUE00
2026-01-162537.5CALL0 257.27TRUE00
2026-01-163037.5CALL0 256.64TRUE00
2026-01-163538CALL0 157.67TRUE00
2026-01-164022.96CALL0 654.02TRUE00
2026-01-164525.3CALL0 455.33TRUE00
2026-01-16500CALL0 054.8FALSE00
2026-01-165523.29CALL0 555.56FALSE00
2026-01-166024.6CALL0 3555.82FALSE00
2026-01-166524.2CALL0 3353.44FALSE00
2026-01-167012.9CALL0 37552.58FALSE00
2026-01-167512.52CALL0 7053.84FALSE00
2026-01-168011.26CALL0 12553.86FALSE00
2026-01-16859.53CALL0 24952.46FALSE00
2026-01-16908.95CALL0 8452.24FALSE00
2026-01-169513.8CALL0 1853.12FALSE00
2026-01-161007.29CALL0 2751.11FALSE00
2026-01-161056.5CALL0 10451.41FALSE00
2026-01-16200.6PUT0 9562.24FALSE00
2026-01-1622.51.2PUT0 1261.22FALSE00
2026-01-16251.25PUT0 2860.27FALSE00
2026-01-16302.25PUT0 7259.08FALSE00
2026-01-16353.4PUT0 6157.85FALSE00
2026-01-16406.36PUT0 5156.69FALSE00
2026-01-16456.9PUT0 3156.1FALSE00
2026-01-165012.8PUT0 109756.03TRUE00
2026-01-165512.8PUT0 74854.85TRUE00
2026-01-166011.55PUT0 1654.37TRUE00
2026-01-166518.55PUT0 1654.35TRUE00
2026-01-167019.5PUT0 8655.81TRUE00
2026-01-167521PUT0 1053.14TRUE00
2026-01-168024.6PUT0 2253.38TRUE00
2026-01-168528.3PUT0 7953.81TRUE00
2026-01-16900PUT0 053.13TRUE00
2026-01-16950PUT0 053.83TRUE00
2026-01-161000PUT0 054.37TRUE00
2026-01-161050PUT0 053.81TRUE00

Latest APLS Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST5$39.4
Jun 13, 2022 7:59 PM EST25$39.4
Jun 13, 2022 7:59 PM EST86$39.39
Jun 13, 2022 7:59 PM EST14$39.4
Jun 13, 2022 7:59 PM EST32$39.4

Apellis Pharmaceuticals, Inc (APLS) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220021048/0001127602-20-021048-index.htm
2020-02-05SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1492422/000083423720004741/0000834237-20-004741-index.htm
2020-02-053/AInitial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320003295/0000899243-20-003295-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320004260/0000899243-20-004260-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320004262/0000899243-20-004262-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320004264/0000899243-20-004264-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320004268/0000899243-20-004268-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320004275/0000899243-20-004275-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320004281/0000899243-20-004281-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320004288/0000899243-20-004288-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320004299/0000899243-20-004299-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320004303/0000899243-20-004303-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320004312/0000899243-20-004312-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320004314/0000899243-20-004314-index.htm
2020-03-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320008068/0000899243-20-008068-index.htm
2020-10-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320027595/0000899243-20-027595-index.htm
2020-10-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320027598/0000899243-20-027598-index.htm
2020-02-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1492422/000090221920000352/0000902219-20-000352-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1492422/000090266420001196/0000902664-20-001196-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1492422/000092963820000336/0000929638-20-000336-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220005685/0001127602-20-005685-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220006429/0001127602-20-006429-index.htm
2020-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220006654/0001127602-20-006654-index.htm
2020-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-03-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220011988/0001127602-20-011988-index.htm
2020-04-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220013334/0001127602-20-013334-index.htm
2020-04-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220013338/0001127602-20-013338-index.htm
2020-04-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220014098/0001127602-20-014098-index.htm
2020-04-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220014100/0001127602-20-014100-index.htm
2020-04-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220014554/0001127602-20-014554-index.htm
2020-05-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220016304/0001127602-20-016304-index.htm
2020-05-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220017178/0001127602-20-017178-index.htm
2020-05-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220017181/0001127602-20-017181-index.htm
2020-06-093Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220019258/0001127602-20-019258-index.htm
2020-06-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220019731/0001127602-20-019731-index.htm
2020-06-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220019733/0001127602-20-019733-index.htm
2020-06-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220019735/0001127602-20-019735-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220021048/0001127602-20-021048-index.htm
2020-07-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220021646/0001127602-20-021646-index.htm
2020-08-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220022885/0001127602-20-022885-index.htm
2020-08-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220023992/0001127602-20-023992-index.htm
2020-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220024043/0001127602-20-024043-index.htm
2020-09-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220024640/0001127602-20-024640-index.htm
2020-09-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220025183/0001127602-20-025183-index.htm
2020-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220026264/0001127602-20-026264-index.htm
2020-10-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220026748/0001127602-20-026748-index.htm
2020-10-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220026750/0001127602-20-026750-index.htm
2020-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220027098/0001127602-20-027098-index.htm
2020-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220027101/0001127602-20-027101-index.htm
2020-11-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220027991/0001127602-20-027991-index.htm
2020-02-27S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1492422/000119312520052855/0001193125-20-052855-index.htm
2020-02-27S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1492422/000119312520052867/0001193125-20-052867-index.htm
2020-04-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1492422/000119312520098977/0001193125-20-098977-index.htm
2020-04-22DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1492422/000119312520115068/0001193125-20-115068-index.htm
2020-04-22DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1492422/000119312520115084/0001193125-20-115084-index.htm
2020-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1492422/000119312520135621/0001193125-20-135621-index.htm
2020-05-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1492422/000119312520141579/0001193125-20-141579-index.htm
2020-06-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1492422/000119312520157384/0001193125-20-157384-index.htm
2020-10-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1492422/000119312520277496/0001193125-20-277496-index.htm
2010-05-19DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1492242/000149224210000001/0001492242-10-000001-index.htm
2020-02-2710-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1492422/000156459020007350/0001564590-20-007350-index.htm
2020-04-2910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1492422/000156459020019689/0001564590-20-019689-index.htm
2020-07-3010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1492422/000156459020034763/0001564590-20-034763-index.htm
2020-11-0210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1492422/000156459020049423/0001564590-20-049423-index.htm
2020-08-24CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1492422/999999999720004458/9999999997-20-004458-index.htm

Apellis Pharmaceuticals, Inc (APLS) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Apellis Pharmaceuticals, Inc (APLS). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 2117%
Institutional Ownership: 8285%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-02-13Pascal DeschateletsChief Operating OfficerSell55,398.0040.982,270,154.641,008,681.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220005685/0001127602-20-005685-index.htm
2020-02-18Cedric FrancoisChief Executive OfficerSell5,000.0040.67203,330.001,027,430.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220006654/0001127602-20-006654-index.htm
2020-02-18Cedric FrancoisChief Executive OfficerSell30,637.0040.661,245,792.331,032,430.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220006654/0001127602-20-006654-index.htm
2020-03-16Cedric FrancoisChief Executive OfficerSell300.0023.867,158.001,053,067.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-03-16Cedric FrancoisChief Executive OfficerSell3,212.0022.2871,556.941,053,367.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-03-16Cedric FrancoisChief Executive OfficerSell15,065.0021.58325,087.641,056,579.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-02-19Cedric FrancoisChief Executive OfficerBuy30,637.002.1465,563.181,058,067.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220006654/0001127602-20-006654-index.htm
2020-02-18Cedric FrancoisChief Executive OfficerBuy30,637.002.1465,563.181,063,067.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220006654/0001127602-20-006654-index.htm
2020-02-13Pascal DeschateletsChief Operating OfficerBuy117,205.002.14250,818.701,064,079.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220005685/0001127602-20-005685-index.htm
2020-02-10Cedric FrancoisChief Executive OfficerBuy34,375.001,066,805.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004299/0000899243-20-004299-index.htm
2020-03-16Cedric FrancoisChief Executive OfficerSell12,060.0020.69249,557.581,071,644.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-10-15Cedric FrancoisChief Executive OfficerSell5,000.0034.46172,300.001,083,079.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220027098/0001127602-20-027098-index.htm
2020-03-17Cedric FrancoisChief Executive OfficerBuy30,637.002.1465,563.181,083,704.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-03-16Cedric FrancoisChief Executive OfficerSell700.0022.2915,600.201,083,704.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-03-16Cedric FrancoisChief Executive OfficerSell2,192.0021.5747,279.251,084,404.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-03-16Cedric FrancoisChief Executive OfficerSell2,108.0020.7343,694.621,086,596.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-09-15Cedric FrancoisChief Executive OfficerSell5,000.0030.96154,800.001,088,079.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220025183/0001127602-20-025183-index.htm
2020-03-16Cedric FrancoisChief Executive OfficerBuy30,637.002.1465,563.181,088,704.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-08-20Cedric FrancoisChief Executive OfficerSell3,457.0030.00103,710.001,093,079.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220024043/0001127602-20-024043-index.htm
2020-08-18Cedric FrancoisChief Executive OfficerSell1,543.0030.0046,290.001,096,536.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220023992/0001127602-20-023992-index.htm
2020-07-15Cedric FrancoisChief Executive OfficerSell5,000.0032.12160,600.001,098,079.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220021646/0001127602-20-021646-index.htm
2020-06-15Cedric FrancoisChief Executive OfficerSell5,000.0030.21151,050.001,103,079.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220019731/0001127602-20-019731-index.htm
2020-05-15Cedric FrancoisChief Executive OfficerSell5,000.0029.92149,600.001,108,079.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220017181/0001127602-20-017181-index.htm
2020-04-15Cedric FrancoisChief Executive OfficerSell5,000.0029.77148,850.001,113,079.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220014100/0001127602-20-014100-index.htm
2020-02-10LUKAS SCHEIBLEROfficerBuy9,375.0012,310.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004314/0000899243-20-004314-index.htm
2020-10-07Victoria L. BrownProgram Team LeadBuy12,000.0018.98227,760.0015,607.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220026748/0001127602-20-026748-index.htm
2020-02-10Timothy Eugene SullivanChief Financial OfficerBuy11,688.0023,387.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004303/0000899243-20-004303-index.htm
2020-02-10Nicole D PerryVice President - FinanceBuy2,500.002,500.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004275/0000899243-20-004275-index.htm
2020-02-10Ahmad SadrOfficerBuy2,725.002,725.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004264/0000899243-20-004264-index.htm
2020-11-02Federico GrossiCHIEF MEDICAL OFFICERSell600.0031.0918,654.0027,725.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220027991/0001127602-20-027991-index.htm
2020-10-01Federico GrossiOfficerSell600.0030.2218,132.0028,325.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220026264/0001127602-20-026264-index.htm
2020-09-01Federico GrossiOfficerSell600.0031.5818,948.0028,925.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220024640/0001127602-20-024640-index.htm
2020-08-03Federico GrossiOfficerSell600.0026.2815,768.0029,525.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220022885/0001127602-20-022885-index.htm
2020-07-01Federico GrossiOfficerSell850.0032.4327,565.5030,125.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220021048/0001127602-20-021048-index.htm
2020-06-15Federico GrossiOfficerSell856.0030.2125,859.7630,975.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220019735/0001127602-20-019735-index.htm
2020-02-10Federico GrossiOfficerBuy9,375.0031,831.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004262/0000899243-20-004262-index.htm
2020-02-10David O. WatsonGeneral CounselSell5,000.0044.50222,500.0035,417.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004260/0000899243-20-004260-index.htm
2020-10-07Victoria L. BrownProgram Team LeadSell12,000.0035.00420,000.003,607.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220026748/0001127602-20-026748-index.htm
2020-02-10David O. WatsonGeneral CounselBuy6,375.0040,417.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004260/0000899243-20-004260-index.htm
2020-02-10David O. WatsonGeneral CounselBuy7,505.002.6720,038.3542,922.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004260/0000899243-20-004260-index.htm
2020-05-08PAUL R. FONTEYNEDirectorBuy5,000.0031.81159,034.005,000.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220016304/0001127602-20-016304-index.htm
2020-02-10Lucia CelonaOfficerBuy5,213.005,213.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004281/0000899243-20-004281-index.htm
2020-02-14Alec MachielsDirectorSell2,500.0042.35105,875.00669,544.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220006429/0001127602-20-006429-index.htm
2020-03-25Alec MachielsDirectorSell2,500.0030.0075,000.00669,544.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220011988/0001127602-20-011988-index.htm
2020-04-15Alec MachielsDirectorSell2,500.0030.0075,000.00669,544.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220014098/0001127602-20-014098-index.htm
2020-05-15Alec MachielsDirectorSell2,500.0030.0075,000.00669,544.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220017178/0001127602-20-017178-index.htm
2020-06-15Alec MachielsDirectorSell2,500.0030.2175,525.00669,544.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220019733/0001127602-20-019733-index.htm
2020-10-07Alec MachielsDirectorSell7,500.0035.00262,500.00669,544.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220026750/0001127602-20-026750-index.htm
2020-10-15Alec MachielsDirectorSell2,500.0035.0087,500.00669,544.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220027101/0001127602-20-027101-index.htm
2020-02-14Alec MachielsDirectorBuy2,500.002.676,675.00672,044.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220006429/0001127602-20-006429-index.htm
2020-03-25Alec MachielsDirectorBuy2,500.002.676,675.00672,044.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220011988/0001127602-20-011988-index.htm
2020-04-15Alec MachielsDirectorBuy2,500.002.676,675.00672,044.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220014098/0001127602-20-014098-index.htm
2020-05-15Alec MachielsDirectorBuy2,500.002.676,675.00672,044.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220017178/0001127602-20-017178-index.htm
2020-06-15Alec MachielsDirectorBuy2,500.002.676,675.00672,044.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220019733/0001127602-20-019733-index.htm
2020-10-15Alec MachielsDirectorBuy2,500.002.676,675.00672,044.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220027101/0001127602-20-027101-index.htm
2020-10-07Alec MachielsDirectorBuy7,500.002.6720,025.00677,044.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220026750/0001127602-20-026750-index.htm
2020-02-10Thomas A. LacknerOfficerBuy2,725.007,725.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004268/0000899243-20-004268-index.htm
2020-02-10Pascal DeschateletsChief Operating OfficerBuy9,375.00891,118.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004312/0000899243-20-004312-index.htm
2020-02-10Adam J. TownsendOfficerBuy9,375.009,375.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004288/0000899243-20-004288-index.htm
2020-02-12Pascal DeschateletsChief Operating OfficerSell52,075.0042.802,228,966.23946,874.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220005685/0001127602-20-005685-index.htm
2020-02-12Pascal DeschateletsChief Operating OfficerBuy117,206.002.14250,820.84998,949.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220005685/0001127602-20-005685-index.htm